The monoclonal antibody revolution has produced a wave of important new therapeutics, but developing effective antibodies remains elusive for many targets and indications. The discovery and ...

Chris Drumm is a lifelong gamer with a BA in English writing and years of experience writing articles and news online. He's played hundreds of games in dozens of genres, enjoyed them all, and put more ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen (NASDAQ: BIIB) announced today the recent initiation of the Phase 2 clinical trial AFFINITY, designed to evaluate opicinumab as an investigational add-on ...

Our team tests, rates, and reviews more than 1,500 products each year to help you make better buying decisions and get more from technology. If you're searching for a professional-grade vector ...